Medacta's NextAR augmented reality shoulder system has been used in more than 1,000 surgeries worldwide, the company said in a Sept. 9 news release.
Since its May launch, the company has placed 100 NextAR platforms in the market.
NextAR is offered with limited capital investment and single-use instrumentation at a low cost per case, providing the ability to host software for multiple applications for both joint and spine surgeries. Medacta said the technology is ideal for the ASC setting.
In the first half of 2022, the company added 80 jobs to expand across new territories and business lines.